BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 16517707)

  • 1. The BZLF1 homolog of an Epstein-Barr-related gamma-herpesvirus is a frequent target of the CTL response in persistently infected rhesus macaques.
    Fogg MH; Garry D; Awad A; Wang F; Kaur A
    J Immunol; 2006 Mar; 176(6):3391-401. PubMed ID: 16517707
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The CD8+ T-cell response to an Epstein-Barr virus-related gammaherpesvirus infecting rhesus macaques provides evidence for immune evasion by the EBNA-1 homologue.
    Fogg MH; Kaur A; Cho YG; Wang F
    J Virol; 2005 Oct; 79(20):12681-91. PubMed ID: 16188971
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibodies to lytic infection proteins in lymphocryptovirus-infected rhesus macaques: a model for humoral immune responses to epstein-barr virus infection.
    Orlova N; Fogg MH; Carville A; Wang F
    Clin Vaccine Immunol; 2011 Sep; 18(9):1427-34. PubMed ID: 21734064
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD4+ and CD8+ T-cell responses to latent antigen EBNA-1 and lytic antigen BZLF-1 during persistent lymphocryptovirus infection of rhesus macaques.
    Leskowitz RM; Zhou XY; Villinger F; Fogg MH; Kaur A; Lieberman PM; Wang F; Ertl HC
    J Virol; 2013 Aug; 87(15):8351-62. PubMed ID: 23698300
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adenovirus-based vaccines against rhesus lymphocryptovirus EBNA-1 induce expansion of specific CD8+ and CD4+ T cells in persistently infected rhesus macaques.
    Leskowitz R; Fogg MH; Zhou XY; Kaur A; Silveira EL; Villinger F; Lieberman PM; Wang F; Ertl HC
    J Virol; 2014 May; 88(9):4721-35. PubMed ID: 24522914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Persistent infection drives the development of CD8+ T cells specific for late lytic infection antigens in lymphocryptovirus-infected macaques and Epstein-Barr virus-infected humans.
    Orlova N; Wang F; Fogg MH
    J Virol; 2011 Dec; 85(23):12821-4. PubMed ID: 21917961
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epstein-Barr Virus gp350 Can Functionally Replace the Rhesus Lymphocryptovirus Major Membrane Glycoprotein and Does Not Restrict Infection of Rhesus Macaques.
    Herrman M; Mühe J; Quink C; Wang F
    J Virol; 2016 Feb; 90(3):1222-30. PubMed ID: 26559839
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immediate early and early lytic cycle proteins are frequent targets of the Epstein-Barr virus-induced cytotoxic T cell response.
    Steven NM; Annels NE; Kumar A; Leese AM; Kurilla MG; Rickinson AB
    J Exp Med; 1997 May; 185(9):1605-17. PubMed ID: 9151898
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selection of a diverse TCR repertoire in response to an Epstein-Barr virus-encoded transactivator protein BZLF1 by CD8+ cytotoxic T lymphocytes during primary and persistent infection.
    Silins SL; Cross SM; Elliott SL; Pye SJ; Burrows JM; Moss DJ; Misko IS
    Int Immunol; 1997 Nov; 9(11):1745-55. PubMed ID: 9418135
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An Epstein-Barr virus encoded inhibitor of Colony Stimulating Factor-1 signaling is an important determinant for acute and persistent EBV infection.
    Ohashi M; Fogg MH; Orlova N; Quink C; Wang F
    PLoS Pathog; 2012 Dec; 8(12):e1003095. PubMed ID: 23300447
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel simian immunodeficiency virus CTL epitopes restricted by MHC class I molecule Mamu-B*01 are highly conserved for long term in DNA/MVA-vaccinated, SHIV-challenged rhesus macaques.
    Su J; Luscher MA; Xiong Y; Rustam T; Amara RR; Rakasz E; Robinson HL; MacDonald KS
    Int Immunol; 2005 May; 17(5):637-48. PubMed ID: 15824066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic vaccination against the rhesus lymphocryptovirus EBNA-1 homologue, rhEBNA-1, elicits T cell responses to novel epitopes in rhesus macaques.
    Silveira EL; Fogg MH; Leskowitz RM; Ertl HC; Wiseman RW; O'Connor DH; Lieberman P; Wang F; Villinger F
    J Virol; 2013 Dec; 87(24):13904-10. PubMed ID: 24089556
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Soluble rhesus lymphocryptovirus gp350 protects against infection and reduces viral loads in animals that become infected with virus after challenge.
    Sashihara J; Hoshino Y; Bowman JJ; Krogmann T; Burbelo PD; Coffield VM; Kamrud K; Cohen JI
    PLoS Pathog; 2011 Oct; 7(10):e1002308. PubMed ID: 22028652
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cloning of the Epstein-Barr virus-related rhesus lymphocryptovirus as a bacterial artificial chromosome: a loss-of-function mutation of the rhBARF1 immune evasion gene.
    Ohashi M; Orlova N; Quink C; Wang F
    J Virol; 2011 Feb; 85(3):1330-9. PubMed ID: 21084476
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dominant cytotoxic T lymphocyte response to the immediate-early trans-activator protein, BZLF1, in persistent type A or B Epstein-Barr virus infection.
    Elliott SL; Pye SJ; Schmidt C; Cross SM; Silins SL; Misko IS
    J Infect Dis; 1997 Oct; 176(4):1068-72. PubMed ID: 9333169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Class I major histocompatibility complex-restricted cytotoxic T lymphocytes specific for Epstein-Barr virus (EBV)-transformed B lymphoblastoid cell lines against which they were raised.
    Hill AB; Lee SP; Haurum JS; Murray N; Yao QY; Rowe M; Signoret N; Rickinson AB; McMichael AJ
    J Exp Med; 1995 Jun; 181(6):2221-8. PubMed ID: 7539044
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of seventeen new simian immunodeficiency virus-derived CD8+ T cell epitopes restricted by the high frequency molecule, Mamu-A*02, and potential escape from CTL recognition.
    Loffredo JT; Sidney J; Wojewoda C; Dodds E; Reynolds MR; Napoé G; Mothé BR; O'Connor DH; Wilson NA; Watkins DI; Sette A
    J Immunol; 2004 Oct; 173(8):5064-76. PubMed ID: 15470050
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rhesus lymphocryptovirus infection during the progression of SAIDS and SAIDS-associated lymphoma in the rhesus macaque.
    Habis A; Baskin G; Simpson L; Fortgang I; Murphey-Corb M; Levy LS
    AIDS Res Hum Retroviruses; 2000 Jan; 16(2):163-71. PubMed ID: 10659055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isolation of cytotoxic T lymphocytes from healthy seropositive individuals specific for peptide epitopes from Epstein-Barr virus nuclear antigen 1: implications for viral persistence and tumor surveillance.
    Khanna R; Burrows SR; Steigerwald-Mullen PM; Thomson SA; Kurilla MG; Moss DJ
    Virology; 1995 Dec; 214(2):633-7. PubMed ID: 8553567
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular evidence for rhesus lymphocryptovirus infection of epithelial cells in immunosuppressed rhesus macaques.
    Kutok JL; Klumpp S; Simon M; MacKey JJ; Nguyen V; Middeldorp JM; Aster JC; Wang F
    J Virol; 2004 Apr; 78(7):3455-61. PubMed ID: 15016868
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.